Back to Results
First PageMeta Content
Transcription factors / Acute leukemia / Myeloid leukemia / Apoptosis / Programmed cell death / Acute promyelocytic leukemia / Histone deacetylase inhibitor / Acute myeloid leukemia / Histone deacetylase / Biology / Medicine / Oncology


Histone deacetylase inhibitors induce See related Commentary on pages 1277–1278. remission in transgenic models of therapy-resistant acute promyelocytic leukemia
Add to Reading List

Open Document

File Size: 754,54 KB

Share Result on Facebook

City

Gainesville / York / Middlebush / Piscataway / Santa Clarita / Hercules / Keene / Vancouver / Indianapolis / Bethesda / Richmond / Rockford / St. Louis / Roberts / Sporn / Valencia / Baltimore / Palo Alto / New York / Alto / Turku / Louis / Sunnyvale / San Diego / L.A. / /

Company

Chemical Co. / Adria / Becton Dickinson & Co. / Elan Pharmaceutical Research Corp. / Genome Systems Inc. / QIAGEN Inc. / Pierce Chemical Co. / IgG / Upstate Biotechnology Inc. / GenBank / Incyte Genomics Inc. / Olympus / Raven Press / Amersham Pharmacia Biotech Inc. / RA / Sambucetti L.C. / GM / Bio-Rad Laboratories Inc. / Aton Pharma Inc. / /

Country

Canada / Finland / United States / /

Currency

pence / /

/

Facility

Columbia University / HDAC1 complex / Memorial Sloan-Kettering Cancer Center / RAR/RXR complex / Pier Paolo Pandolfi / Cornell University / National Cancer Institute / Sloan-Kettering Institute / HDAC complex / /

/

IndustryTerm

cancer therapy / treatment of acute promyelocytic leukemia / therapy for cancer / Cancer Treatment / therapy of acute promyelocytic leukemia / /

MedicalCondition

Retinoblastoma / several tumor / human tumors / prostate cancer / acute promyelocytic-like leukemia / leukemia / tumor / Avian erythroleukemia / cancer / acute promyelocytic leukaemia / malaria / acute myeloid leukemia / lymphoma / human acute promyelocytic leukemia / acute promyelocytic leukaemia myl/RARα cDNA / Acute promyelocytic leukemia / APL-like leukemias / leukemias / promyelocytic leukemia / rare syndrome / cancers / promyelocytic leukaemia / human leukemia / disease / Acute leukemia / nonHodgkin’s lymphomas / myeloid leukemia / diffuse large-cell non-Hodgkins lymphoma / p53 tumor / toxoplasmosis / B-cell lymphoma / /

MedicalTreatment

cancer therapy / Chemoprevention / chemotherapy / /

Organization

Columbia University / Leukemia-Lymphoma Society of America / Leukemia Society of America / SAHA administration / National Cancer Institute / National Institute of Health / Sloan-Kettering Institute / Department of Pathology / Charles H. Revson Foundation / Sloan-Kettering Division / De Witt Wallace Fund / Graduate School / Cornell University / New York / /

Person

Gene Expr / Nat / Richard A. Rifkind / R.P. Warrell / Jr. / Victoria M. Richon / P.P. Pandolfi / V.M. Richon / I. Magrath / Paul A. Marks / /

/

Position

mediator / Butler / DR5-Luciferase reporter / representative / Hb / editor / µg DR5-Luc reporter / Dean / reporter / Scholar / /

Product

tretinoin / acetic acid / FR901228 / penicillin / Quest / /

ProgrammingLanguage

APL / /

ProvinceOrState

Virginia / M.B. / Indiana / British Columbia / New York / Missouri / California / Georgia / Texas / New Jersey / A.B. / Maryland / Illinois / New Hampshire / /

PublishedMedium

Journal of Clinical Investigation / the Oligotex The Journal / The Journal of Clinical Investigation / /

Technology

apoptosis / DNA Chip / gene expression / chemotherapy / treating cancer / alpha / antibodies / Cloning / /

SocialTag